T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation
Katsuyama, Naoya, Kawase, Takakazu, Barakat, Carolyne, Mizuno, Shohei, Tomita, Akihiro, Ozeki, Kazutaka, Nishio, Nobuhiro, Sato, Yoshie, Kajiya, Ryoko, Shiraishi, Keiko, Takahashi, Yoshiyuki, Ichinohe, Tatsuo, Nishikawa, Hiroyoshi, Akatsuka, Yoshiki
Published in Nagoya journal of medical science (01.11.2023)
Published in Nagoya journal of medical science (01.11.2023)
Get full text
Journal Article
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation
Barakat, Carolyne, Inagaki, Yuichiro, Mizuno, Shohei, Nishio, Nobuhiro, Katsuyama, Naoya, Sato, Yoshie, Kobayashi, Miki, Ozeki, Kazutaka, Iida, Hiroatsu, Tomita, Akihiro, Sawa, Masashi, Demachi-Okamura, Ayako, Takahashi, Yoshiyuki, Nishikawa, Hiroyoshi, Akatsuka, Yoshiki
Published in International journal of hematology (01.08.2023)
Published in International journal of hematology (01.08.2023)
Get full text
Journal Article